Dexcom G4 Pediatric Approval.

From: http://investor.shareholder.com/dexcom/releaseDetail.cfm?ReleaseID=822940

Innovative Dexcom G4® PLATINUM Continuous Glucose Monitor (CGM) Receives FDA Approval for Use in Children Ages 2 to 17 Years 

Now Children Can Gain Better Control of Their Diabetes with Advanced CGM Technology 

SAN DIEGO--(BUSINESS WIRE)-- Dexcom, Inc., (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM), announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM device: Dexcom G4® PLATINUM (Pediatric) for use in children ages 2 to 17 years with diabetes. Already approved for adults 18 and older, the Dexcom G4 PLATINUM (Pediatric) is now the only CGM system approved for children as young as two years old.

Also from FDA: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm384495.htm#.UvAi884z4jM.facebook